FDA.reportPublic FDA data

Application 213260

Type
NDA
Sponsor
CMP DEV LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ATORVALIQATORVASTATIN CALCIUMSUSPENSION;ORAL20MG/5MLYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
78238SUPPL 2024-04-24
78232SUPPL 2024-04-24
73512ORIG 2023-02-16
73367ORIG 2023-02-02
73365ORIG 2023-02-02